Beginning May 26, 2020, literature reviews will play a key role throughout clinical evaluation reports under new MEDDEV regulations, including in the establishment of state of the art, according to a tHEORetically Speaking blog post by Evidence Partners Director of Marketing and Communications Susan Sykes.
But under new regulations, what could potentially go wrong with a literature review?
One potential problem, according to the post, could be incomplete coverage in a bid to expedite the process.
“It may be tempting to try to speed up the screening process with a narrower search, but if any potentially relevant articles are shown to be missing from the results, it can call into question the validity of the entire literature review,” Sykes writes.
The strength of the data in one’s literature review can also open the door for some major errors, according to the post, as “small mistakes can be just as disastrous as big ones.”
“Typos, inconsistencies in data entry, transcription errors, or undocumented manual decisions can all derail your literature review as easily as leaving out a key citation,” Sykes writes.